GlassScriptPhysician profile
Curtis Foster
NPI 1477710028
$355.14
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $68.98 · 2021: $41.98 · 2022: $44.20.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $75.81 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $71.96 | 2020-2022 | |
| Lilly USA, LLC | $42.14 | 2019 | |
| Acclarent, INC | $29.16 | 2019 | |
| Arbor Pharmaceuticals, INC. | $28.35 | 2019 | |
| Abbvie INC. | $27.89 | 2021 | |
| Astellas Pharma US INC | $26.66 | 2019-2020 | |
| Horizon Therapeutics Plc | $15.05 | 2019 | |
| Novo Nordisk INC | $14.67 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.04 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.41 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.